BioCryst Pharmaceuticals BCRX shares are trading higher after the company reported better-than-expected Q1 sales results.
BioCryst Pharmaceuticals' stock has been rising Thursday, up 20.78% to a price of $12.84. The stock's current volume for the day is 15.49 million, which is approximately 405.03% of its previous 30-day average volume of 3.82 million.
The moving average price of the stock over the past 50 days was $11.36 at the time this article was published. In the past fifty-two weeks, the stock price has been as high as $14.24 and as low as $3.3.
Benzinga Pro provides investors with timely and accurate explanations of why a stock is moving. Subscribe to receive real-time alerts explaining stock price movements. Click here to learn more.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
